The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-((2-(1-(naphthalen-1-ylsulfonyl)-1H-indol-4-yloxy)ethylamino)methyl)phenyl acetate ID: ALA4874372
PubChem CID: 164626757
Max Phase: Preclinical
Molecular Formula: C29H26N2O5S
Molecular Weight: 514.60
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CC(=O)Oc1ccc(CNCCOc2cccc3c2ccn3S(=O)(=O)c2cccc3ccccc23)cc1
Standard InChI: InChI=1S/C29H26N2O5S/c1-21(32)36-24-14-12-22(13-15-24)20-30-17-19-35-28-10-5-9-27-26(28)16-18-31(27)37(33,34)29-11-4-7-23-6-2-3-8-25(23)29/h2-16,18,30H,17,19-20H2,1H3
Standard InChI Key: VOGBRQUNKLLWPV-UHFFFAOYSA-N
Molfile:
RDKit 2D
37 41 0 0 0 0 0 0 0 0999 V2000
34.9158 -18.8641 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.9147 -19.6923 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.3445 -18.8605 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.6284 -18.4510 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.0580 -18.4449 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
37.7748 -18.8551 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.4883 -18.4395 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.2051 -18.8498 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
39.9188 -18.4341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.6354 -18.8443 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.3478 -19.6938 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.6331 -20.1020 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.8004 -20.9079 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.6187 -20.9979 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.9569 -20.2475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9600 -21.9297 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.2467 -21.5168 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
35.2457 -22.3409 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.4411 -21.3469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1897 -20.5603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3832 -20.3866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8283 -20.9993 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.6356 -19.6702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.3515 -20.0803 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.0662 -19.6647 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.0603 -18.8346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.3439 -18.4283 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.7833 -20.0739 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
43.4965 -19.6574 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.2137 -20.0667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.4922 -18.8316 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.8914 -21.9586 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0883 -21.7873 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.5405 -22.3965 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7946 -23.1771 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.6015 -23.3451 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1459 -22.7346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 12 1 0
11 3 1 0
3 4 2 0
4 1 1 0
3 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
11 12 2 0
12 13 1 0
13 14 1 0
14 15 2 0
15 11 1 0
17 16 2 0
18 17 2 0
13 17 1 0
17 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 33 1 0
32 19 1 0
10 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 10 1 0
25 28 1 0
28 29 1 0
29 30 1 0
29 31 2 0
32 33 1 0
33 34 2 0
34 35 1 0
35 36 2 0
36 37 1 0
37 32 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 514.60Molecular Weight (Monoisotopic): 514.1562AlogP: 5.13#Rotatable Bonds: 9Polar Surface Area: 86.63Molecular Species: BASEHBA: 7HBD: 1#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: 8.76CX LogP: 4.80CX LogD: 3.43Aromatic Rings: 5Heavy Atoms: 37QED Weighted: 0.17Np Likeness Score: -0.79
References 1. Wichur T, Godyń J, Góral I, Latacz G, Bucki A, Siwek A, Głuch-Lutwin M, Mordyl B, Śniecikowska J, Walczak M, Knez D, Jukič M, Sałat K, Gobec S, Kołaczkowski M, Malawska B, Brazzolotto X, Więckowska A.. (2021) Development and crystallography-aided SAR studies of multifunctional BuChE inhibitors and 5-HT6 R antagonists with β-amyloid anti-aggregation properties., 225 [PMID:34530376 ] [10.1016/j.ejmech.2021.113792 ]